Thomas A. McCourt
2013
In 2013, Thomas A. McCourt earned a total compensation of $1.1M as Senior Vice President, Marketing and Sales and Chief Commercial Officer at Ironwood Pharmaceuticals, a 4% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $81,825 |
|---|---|
| Option Awards | $675,455 |
| Salary | $366,600 |
| Other | $7,440 |
| Total | $1,131,320 |
McCourt received $675.5K in option awards, accounting for 60% of the total pay in 2013.
McCourt also received $81.8K in non-equity incentive plan, $366.6K in salary and $7.4K in other compensation.
Rankings
In 2013, Thomas A. McCourt's compensation ranked 6,068th out of 12,286 executives tracked by ExecPay. In other words, McCourt earned more than 50.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,068 out of 12,286 | 51st |
Division Manufacturing | 2,112 out of 4,612 | 54th |
Major group Chemicals And Allied Products | 622 out of 1,462 | 58th |
Industry group Drugs | 446 out of 1,156 | 61st |
Industry Pharmaceutical Preparations | 358 out of 890 | 60th |
Source: SEC filing on April 15, 2016.
McCourt's colleagues
We found three more compensation records of executives who worked with Thomas A. McCourt at Ironwood Pharmaceuticals in 2013.
News
Ironwood Pharmaceuticals CEO Thomas McCourt's 2021 pay jumps 158% to $8.8M
April 21, 2022
Ironwood Pharmaceuticals CEO Mark Mallon's 2020 pay falls 32% to $6.8M
April 22, 2021
Ironwood Pharmaceuticals CEO Mark Mallon receives $10M in 2019
April 21, 2020
Ironwood Pharmaceuticals CEO Peter Hecht's 2018 pay slips 14% to $5.2M
April 26, 2019